Categories
Hester Biosciences Limited — Updates, 15-05-2026: Press Release
15-05-2026 · 12:03 pm
Hester Bio reports strong Q4: Standalone Revenue up 22%, Profit jumped 174%. Consolidated Profit surged 974%. A dividend of ₹11/share was declared. Poultry segment fueled growth, boosted by new H9N2 Avian Influenza vaccine license and capacity expansion.
No comments yet. Be the first to comment!